NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Gross Margin (2015 - 2026)

NextPlat's (NXPL) quarterly Gross Margin came in at 39.51% in Q2 2026, up 1773.0% year-over-year from 2.11% in Q2 2025, and up 14.11% quarter-over-quarter from 34.62% in Q1 2026.

Analysis

NextPlat (NXPL) Gross Margin (2015 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Gross Margin for 12 consecutive years, with 39.51% the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Gross Margin rose 1773.0% year-over-year to 39.51% in Q2 2026; TTM through Jun 2026 was 26.23%, a 575.0% increase from a year earlier, with the FY2025 full-year figure at 20.08%, down 566.0% from the prior year.
  • Gross Margin was 39.51% for Q2 2026 at NextPlat, up from 34.62% in the prior quarter.
  • Over five years, Gross Margin peaked at 39.51% in Q2 2026 and troughed at 14.29% in Q4 2025.
  • A 5-year average of 24.96% and a median of 22.77% in 2024 frame the typical range for Gross Margin.
  • Across the five-year window, Gross Margin plunged 1482 bps in 2024 and surged 1773 bps in 2026, its largest moves.
  • Over 5 years, Gross Margin stood at 16.8% in 2022, then surged by 88 bps to 31.64% in 2023, then tumbled by 47 bps to 16.81% in 2024, then retreated by 15 bps to 14.29% in 2025, then surged by 176 bps to 39.51% in 2026.
  • The last three Gross Margin figures came in at 39.51% (Q2 2026), 34.62% (Q1 2026), and 14.29% (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 51.98%
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 38.77%
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 46.52%
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 42.01%
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 73.60%
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 62.35%
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 4.68%
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 50.83%
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 95.97%
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn 39.51%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.51%
Mar 31, 2026 34.62%
Dec 31, 2025 14.29%
Sep 30, 2025 19.85%
Jun 30, 2025 21.77%
Mar 31, 2025 20.57%
Dec 31, 2024 16.81%
Sep 30, 2024 23.15%
Jun 30, 2024 34.48%
Mar 31, 2024 27.80%
Dec 31, 2023 31.64%
Sep 30, 2023 29.99%
Jun 30, 2023 28.54%
Mar 31, 2023 21.59%
Dec 31, 2022 16.80%
Sep 30, 2022 25.80%
Jun 30, 2022 19.76%
Mar 31, 2022 22.39%
Dec 31, 2021 18.71%
Sep 30, 2021 21.91%